Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TNGX
TNGX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TNGX News
Tango Therapeutics Successfully Prices Public Offering
Jun 10 2026
NASDAQ.COM
Tango Therapeutics Prices Upsized $600M Public Offering
Jun 10 2026
seekingalpha
Tango Therapeutics Prices $600 Million Underwritten Offering
Jun 10 2026
Newsfilter
Tango Therapeutics Prices $600 Million Underwritten Offering
Jun 10 2026
Yahoo Finance
Tango Therapeutics Shares Surge Over 50% on Positive Trial Data
Jun 09 2026
NASDAQ.COM
Tango Therapeutics Launches $500M Underwritten Public Offering
Jun 08 2026
seekingalpha
Tango Therapeutics Raises Drug Sales Estimate to $2.6 Billion
Jun 08 2026
stocktwits
Tango Therapeutics Shares Surge 32% on Promising Trial Data for Vopimetostat
Jun 08 2026
seekingalpha
RTW Investments Increases Stake in Tango Therapeutics
May 30 2026
NASDAQ.COM
RTW Investments Acquires 11.8 Million Shares of Tango Therapeutics
May 30 2026
Fool
Boxer Capital Acquires $17.55 Million Stake in Corvus Pharmaceuticals
May 17 2026
Yahoo Finance
Tango Therapeutics Stock Recovery Opportunity Amid Analyst Upgrades
May 15 2026
stocktwits
Tango Therapeutics Q1 Earnings Miss Expectations
May 13 2026
seekingalpha
Tango Therapeutics Grants Stock Options and RSUs to Executives
May 04 2026
Newsfilter
Tango Therapeutics Appoints New CFO and Executives to Accelerate Growth
Apr 15 2026
Newsfilter
Revolution's Cancer Drug Shows Promising Results in Trials
Apr 13 2026
stocktwits
Show More News
